journal article·2024-10Open access

Surface Crystal and Degradability of Shape Memory Scaffold Essentialize Osteochondral Regeneration

Sungwoo Cho, Kang Suk Lee, Kyubae Lee, Hye‐Seon Kim, Suji Park, Seung Eun Yu, Hyunsu Ha, Sewoom Baek, Jueun Kim, Hyunjae Kim, Ji Youn Lee, Sangmin Lee, Hak‐Joon Sung

Small· Volume 20· Issue 40

Abstract

Abstract The minimally invasive deployment of scaffolds is a key safety factor for the regeneration of cartilage and bone defects. Osteogenesis relies primarily on cell‐matrix interactions, whereas chondrogenesis relies on cell–cell aggregation. Bone matrix expansion requires osteoconductive scaffold degradation. However, chondrogenic cell aggregation is promoted on the repellent scaffold surface, and minimal scaffold degradation supports the avascular nature of cartilage regeneration. Here, a material satisfying these requirements for osteochondral regeneration is developed by integrating osteoconductive hydroxyapatite (HAp) with a chondroconductive shape memory polymer (SMP). The shape memory function‐derived fixity and recovery of the scaffold enabled minimally invasive deployment and expansion to fill irregular defects. The crystalline phases on the SMP surface inhibited cell aggregation by suppressing water penetration and subsequent protein adsorption. However, HAp conjugation SMP (H‐SMP) enhanced surface roughness and consequent cell‐matrix interactions by limiting cell aggregation using crystal peaks. After mouse subcutaneous implantation, hydrolytic H‐SMP accelerated scaffold degradation compared to that by the minimal degradation observed for SMP alone for two months. H‐SMP and SMP are found to promote osteogenesis and chondrogenesis, respectively, in vitro and in vivo, including the regeneration of rat osteochondral defects using the binary scaffold form, suggesting that this material is promising for osteochondral regeneration.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Osteoarthritis Treatment and Mechanisms · Bone Metabolism and Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medical Engineering Yonsei University College of Medicine 50–1 Yonsei‐ro, Seodaemun‐gu Seoul 03722 Republic of Korea

TMD LAB Co. Ltd. 6th Floor, 31, Gwangnaru‐ro 8‐gil, Seongdong‐gu Seoul 04799 South Korea

Department of Biomedical Materials Konyang University 158, Gwanjeodong‐ro, Seo‐gu Daejeon 35365 South Korea

Department of Anesthesiology, Perioperative, and Pain Medicine Brigham and Women's Hospital Harvard Medical School Boston MA 02115 USA

Department of Brain Korea 21 FOUR Project for Medical Science Yonsei University College of Medicine 50–1 Yonsei‐ro, Seodaemun‐gu Seoul 03722 Republic of Korea

Funding

National Research Foundation of Korea

References (39)

Show source-provided references
1. 10.1038/s41584-023-00979-510.1038/s41584-023-00979-5 ↗
2. 10.1002/advs.20220005010.1002/advs.202200050 ↗
3. Wenying W. · Bioact. Mater · 2021 · 6 · 4830
4. Clouet J. · Drug Discov. Today Technol. · 2009 · 14 · 19
5. 10.3349/ymj.2016.57.6.152710.3349/ymj.2016.57.6.1527 ↗
6. 10.1038/nrrheum.2009.20410.1038/nrrheum.2009.204 ↗
7. GTEx Consortium Nature2017 550 204.10.1038/nature24277 ↗
8. 10.1016/j.actbio.2019.11.00110.1016/j.actbio.2019.11.001 ↗
9. 10.1016/j.bioactmat.2022.10.02910.1016/j.bioactmat.2022.10.029 ↗
10. 10.1016/j.mattod.2017.07.00210.1016/j.mattod.2017.07.002 ↗
11. 10.1016/j.bioactmat.2021.12.00510.1016/j.bioactmat.2021.12.005 ↗
12. 10.1002/adfm.20201060910.1002/adfm.202010609 ↗
13. 10.1016/S1369-7021(04)00233-010.1016/S1369-7021(04)00233-0 ↗
14. 10.1016/j.biomaterials.2019.11954810.1016/j.biomaterials.2019.119548 ↗
15. 10.1016/j.progpolymsci.2022.10155610.1016/j.progpolymsci.2022.101556 ↗
16. Wang Y. · ACS Appl. Mater. Interfaces · 2021 · 13
17. 10.1038/s41576-020-00292-x10.1038/s41576-020-00292-x ↗
18. 10.1021/acs.nanolett.7b0498210.1021/acs.nanolett.7b04982 ↗
19. 10.1021/acsami.5b0812610.1021/acsami.5b08126 ↗
20. 10.1073/pnas.131000311010.1073/pnas.1310003110 ↗
21. 10.1038/s41536-022-00269-w10.1038/s41536-022-00269-w ↗
22. 10.1126/sciadv.add421010.1126/sciadv.add4210 ↗
23. 10.1016/j.mattod.2017.10.00510.1016/j.mattod.2017.10.005 ↗
24. 10.1016/j.bioactmat.2023.03.01710.1016/j.bioactmat.2023.03.017 ↗
25. 10.4248/BR20130300110.4248/BR201303001 ↗
26. 10.1016/j.biomaterials.2004.11.03710.1016/j.biomaterials.2004.11.037 ↗
27. 10.1002/adhm.20220024610.1002/adhm.202200246 ↗
28. 10.1016/j.bioactmat.2021.03.04310.1016/j.bioactmat.2021.03.043 ↗
29. 10.1016/j.bioactmat.2018.05.00610.1016/j.bioactmat.2018.05.006 ↗
30. 10.1038/s41467-019-09839-x10.1038/s41467-019-09839-x ↗
31. 10.1038/s41536-017-0021-410.1038/s41536-017-0021-4 ↗
32. 10.1038/nrrheum.2016.14810.1038/nrrheum.2016.148 ↗
33. 10.1016/j.matt.2022.06.00310.1016/j.matt.2022.06.003 ↗
34. 10.1021/acsnano.6b0164910.1021/acsnano.6b01649 ↗
35. 10.1016/j.bioactmat.2017.10.00110.1016/j.bioactmat.2017.10.001 ↗
36. 10.1016/j.actbio.2011.03.01910.1016/j.actbio.2011.03.019 ↗
37. 10.1002/adma.20190447610.1002/adma.201904476 ↗
38. 10.1039/C7TB01350G10.1039/C7TB01350G ↗
39. 10.3349/ymj.2022.007810.3349/ymj.2022.0078 ↗